In breast cancer tissues, increased levels of BRF1 were associated with high ER (estrogen receptor) levels; ERα was then found to associate with the BRF1 promoter and increase its expression in breast cancer cell lines, and to interact with BRF1. The gene discussed is BRF1; the disease is breast carcinoma.